Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2013 June;38(2) > Minerva Endocrinologica 2013 June;38(2):181-5

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118


eTOC

 

ORIGINAL ARTICLES  


Minerva Endocrinologica 2013 June;38(2):181-5

language: English

Diet and physical activity “defeated” Tuberil® in treatment of childhood obesity

Ferrara P. 1, Del Bufalo F. 2, Ianniello F. 1, Franceschini A. 3, Paolini Paoletti F. 4, Massart F. 5, Saggese G. 5

1 Department of Pediatric Sciences, A. Gemelli University Hospital, Rome, Italy;
2 Campus Bio-Medico University, Rome, Italy;
3 Department of Pediatrics, Perugia University Perugia, Italy;
4 Pediatrician of the National Health System Gualdo Tadino, Perugia, Italy;
5 Department of Pediatrics, Pisa University Hospital, Pisa, Italy


PDF  


Aim: Childhood obesity is remarkably spreading worldwide, involving both industrialized and low-income countries. Its prevalence, outcome and socioeconomic impact call for the attention of medical community. We conducted a monocentric, open, two-arm, parallel-group study to evaluate the efficacy at reducing appetite and increasing dietary compliance of obese children of Tuberil®, a weight-loss supplement derived from potato and devoid of side effects.
Methods: We recruited participants, children with BMI ≥85th, through direct referrals in pediatrician’s surgeries. Children were randomized to receive Tuberil® (group A) or nothing (group B), following a chronological order (A-B-A-B). Every child received a nutritionally balanced diet and had to record their appetite and to describe their meals in a diary.
Results: Even if we found a significant reduction in BMI, weight and waist circumference in both groups, no statistically significant differences between groups were noted. We did not found any significant differences in appetite between group A and B.
Conclusion: Our data show that Tuberil® has no efficacy neither in reducing appetite in children nor in increasing dietary compliance. We believe that only a nutritionally balanced diet and our attention in verifying their compliance led to the reduction in BMI, weight and waist circumferences noted in our series.

top of page

Publication History

Cite this article as

Corresponding author e-mail

pferrara@rm.unicatt.it